Research output per year
Research output per year
Description
Additional file 4: Figure S4. The resistant primary cells (GBM#1) were pretreated with siRNA for SOD2 knockdown. The cells were then incubated in low serum (2%) cultures medium with or without TMZ. The western blotting result of cleaved caspase 3 after TMZ treatment was shown. (n = 3 for each group, Data are presented as mean ± standard error, *P
| Date made available | 2019 |
|---|---|
| Publisher | Figshare |
Research output
- 1 Article
-
Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets
Chien, C. H., Chuang, J. Y., Yang, S. T., Yang, W. B., Chen, P. Y., Hsu, T. I., Huang, C. Y., Lo, W. L., Yang, K. Y., Liu, M. S., Chu, J. M., Chung, P. H., Liu, J. J., Chou, S. W., Chen, S. H. & Chang, K. Y., Oct 19 2019, In: Journal of Biomedical Science. 26, 1, 77.Research output: Contribution to journal › Article › peer-review
Open Access25 Citations (Scopus)